Clinical Trial Update: Study to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®) in HIV+ Patients [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the effect of nevirapine on the steady-state pharmacokinetics of rifabutin in HIV-infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Mycobutin (rifabutin)
• Viramune (Nevirapine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 4 | Status: COMPLETED